Clinical trial

EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes

NCT01808690

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE3

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2021-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

PlaceboDRUG

Sponsors & collaborators

University of Colorado, Denverlead sponsor

American Diabetes Associationcollaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01808690 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.